Home › Companies › Harmony Biosciences Holdings, Inc. › 2025-2026

Harmony Biosciences Holdings, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Harmony Biosciences Holdings, Inc.’s Form 8-K, filed May 14, 2026 (Item 5.07 on EDGAR). Page generated November 7, 2026.

  • 6Ballot items
  • 344Asset managers
  • 2,502Fund votes
  • May 14, 2026Meeting date

Results at a glance

Meeting of May 14, 2026: 6 items on Harmony Biosciences Holdings, Inc.’s Form 8-K, filed May 14, 2026: 4 elected · 2 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Harmony Biosciences Holdings, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Harmony Biosciences Holdings, Inc.

These tallies are Harmony Biosciences Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 14, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Harmony Biosciences Holdings, Inc. — official shareholder meeting results, meeting held May 14, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Geno Germano 44,963,163---- 1,524,1423,894,004 97%Elected—
Elect Director: Troy Ignelzi 32,813,495---- 13,673,8103,894,004 71%Elected—
Elect Director: Ron Philip 31,826,838---- 14,660,4673,894,004 68%Elected—
Elect Director: Andreas Wicki, Ph.D. 25,114,526---- 21,372,7793,894,004 54.0%Elected—
2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 49,385,510830,697165,102 ---- 98%Approved—
3. The approval on a non-binding, advisory basis, of the compensation of the Company's named executive officers pursuant to the SEC's compensation disclosure rules 33,249,86213,042,898194,545 --3,894,004 72%Approved—

Source: Harmony Biosciences Holdings, Inc., Form 8-K, filed with the SEC on May 14, 2026 — read the filing on EDGAR.

How asset managers voted at the Harmony Biosciences Holdings, Inc. 2025-2026 meeting

Each item below shows how the 344 asset managers that disclosed a Harmony Biosciences Holdings, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Andreas Wicki, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

54.0% Majority: yes · of votes cast

FOR 54.0%WITHHELD
FOR: 25,114,526WITHHELD: 21,372,779
Details: description as filed, official tally, votes by 99 asset managers

Description as filed by funds: The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Andreas Wicki, Ph.D.

Harmony Biosciences Holdings, Inc.’s own tally for this item (“Elect Director: Andreas Wicki, Ph.D.”): 25,114,526 for, 21,372,779 withheld, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each of the director nominees was duly elected.”
Support: 54.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 99 asset managers below reported 9,583,802 for, 6,459,790 withheld, 3,801,856 abstained.

FORABSTAINWITHHOLD
FOR: 9,583,802ABSTAIN: 3,801,856WITHHOLD: 6,459,790
Largest asset managers voting on “The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until thei” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,653,3060 680For
BlackRock00 3,594,2550Abstain
Fidelity2,756,1800 043,407For
American Century00 01,977,227Withhold
State Street1,3760 0678,001Withhold
Dimensional00 0660,050Withhold
Invesco00 0515,987Withhold
Charles Schwab380,6380 00For
Royce00 0341,516Withhold
MFS00 0266,264Withhold
Pacer Funds Trust262,8440 00For
Bridge Builder Trust220,5000 8,4000For
ADVISORS' INNER CIRCLE FUND218,8440 00For
Federated Hermes179,0870 00For
Victory Capital00 0174,136Withhold
Allspring00 0167,227Withhold
RBB FUND, INC.00 0160,775Withhold
Goldman Sachs125,4710 020,299Mixed
World Funds Trust127,8230 00For
SEI119,9500 00For
Prudential/PGIM48,2290 071,179Mixed
Equitable00 0102,014Withhold
First Trust00 095,151Withhold
OPTIMUM FUND TRUST87,9000 00For
EA Series Trust87,2020 00For

Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.

2. Elect Director: Geno Germano

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 44,963,163WITHHELD: 1,524,142
Details: description as filed, official tally, votes by 99 asset managers

Description as filed by funds: The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Geno J. Germano

Harmony Biosciences Holdings, Inc.’s own tally for this item (“Elect Director: Geno Germano”): 44,963,163 for, 1,524,142 withheld, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each of the director nominees was duly elected.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 99 asset managers below reported 19,581,166 for, 264,276 withheld, 6 abstained.

FOR
FOR: 19,581,166ABSTAIN: 6WITHHOLD: 264,276
Largest asset managers voting on “The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until thei” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,653,3680 60For
BlackRock3,594,2550 00For
Fidelity2,799,5870 00For
American Century1,977,2270 00For
State Street679,3770 00For
Dimensional660,0500 00For
Invesco515,9870 00For
Charles Schwab380,6380 00For
Royce341,5160 00For
MFS266,2640 00For
Pacer Funds Trust262,8440 00For
Bridge Builder Trust228,9000 00For
ADVISORS' INNER CIRCLE FUND218,8440 00For
Federated Hermes179,0870 00For
Victory Capital174,1360 00For
Allspring167,2270 00For
RBB FUND, INC.00 0160,775Withhold
Goldman Sachs125,4710 020,299Mixed
World Funds Trust127,8230 00For
SEI119,9500 00For
Prudential/PGIM55,7900 063,618Mixed
Equitable102,0140 00For
First Trust95,1510 00For
OPTIMUM FUND TRUST87,9000 00For
EA Series Trust87,2020 00For

Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.

3. Elect Director: Ron Philip

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%WITHHELD
FOR: 31,826,838WITHHELD: 14,660,467
Details: description as filed, official tally, votes by 99 asset managers

Description as filed by funds: The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Ron Philip

Harmony Biosciences Holdings, Inc.’s own tally for this item (“Elect Director: Ron Philip”): 31,826,838 for, 14,660,467 withheld, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each of the director nominees was duly elected.”
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 99 asset managers below reported 14,171,219 for, 5,375,813 withheld, 298,416 abstained.

FORWITHHOLD
FOR: 14,171,219ABSTAIN: 298,416WITHHOLD: 5,375,813
Largest asset managers voting on “The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until thei” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,647,5700 445,760For
BlackRock3,594,2550 00For
Fidelity2,798,0920 01,495For
American Century00 01,977,227Withhold
State Street678,6000 0777For
Dimensional00 0660,050Withhold
Invesco515,9870 00For
Charles Schwab380,6380 00For
Royce00 0341,516Withhold
MFS00 0266,264Withhold
Pacer Funds Trust262,8440 00For
Bridge Builder Trust82,3000 146,6000Mixed
ADVISORS' INNER CIRCLE FUND00 0218,844Withhold
Federated Hermes179,0870 00For
Victory Capital00 0174,136Withhold
Allspring00 0167,227Withhold
RBB FUND, INC.00 0160,775Withhold
Goldman Sachs125,4710 020,299Mixed
World Funds Trust127,8230 00For
SEI00 0119,950Withhold
Prudential/PGIM48,2290 071,179Mixed
Equitable63,5940 038,420Mixed
First Trust00 095,151Withhold
OPTIMUM FUND TRUST00 087,900Withhold
EA Series Trust87,2020 00For

Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.

4. Elect Director: Troy Ignelzi

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD
FOR: 32,813,495WITHHELD: 13,673,810
Details: description as filed, official tally, votes by 99 asset managers

Description as filed by funds: The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy Ignelzi

Harmony Biosciences Holdings, Inc.’s own tally for this item (“Elect Director: Troy Ignelzi”): 32,813,495 for, 13,673,810 withheld, per its Form 8-K filed May 14, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each of the director nominees was duly elected.”
Support: 71% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 99 asset managers below reported 11,877,224 for, 4,302,955 withheld, 3,665,268 abstained.

FORABSTAINWITHHOLD
FOR: 11,877,224ABSTAIN: 3,665,268WITHHOLD: 4,302,955
Largest asset managers voting on “The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until thei” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard1,948,7280 492,704,596Mixed
BlackRock220,5990 3,373,6560Mixed
Fidelity2,780,4840 019,103For
American Century1,977,2270 00For
State Street679,3770 00For
Dimensional660,0500 00For
Invesco515,9870 00For
Charles Schwab00 0380,638Withhold
Royce341,5160 00For
MFS00 0266,264Withhold
Pacer Funds Trust262,8440 00For
Bridge Builder Trust73,9000 155,0000Mixed
ADVISORS' INNER CIRCLE FUND00 0218,844Withhold
Federated Hermes179,0870 00For
Victory Capital174,1360 00For
Allspring167,2270 00For
RBB FUND, INC.00 0160,775Withhold
Goldman Sachs125,4710 020,299Mixed
World Funds Trust127,8230 00For
SEI00 0119,950Withhold
Prudential/PGIM7,5610 0111,847Mixed
Equitable38,4200 063,594Mixed
First Trust95,1510 00For
OPTIMUM FUND TRUST00 087,900Withhold
EA Series Trust87,2020 00For

Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.

5. 3. The approval on a non-binding, advisory basis, of the compensation of the Company's named executive officers…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

72% Approved · of votes cast

FOR 72%AGAINST
FOR: 33,249,862AGAINST: 13,042,898
Details: description as filed, official tally, votes by 344 asset managers

Description as filed by funds: Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules.

Harmony Biosciences Holdings, Inc.’s own tally for this item (“3. The approval on a non-binding, advisory basis, of the compensation of the Company's named executive officers pursuant to the SEC's compensation disclosure rules”): 33,249,862 for, 13,042,898 against — passed, per its Form 8-K filed May 14, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the shareholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers pursuant to the SEC's compensation disclosure rules.”
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 98 asset managers voting on “Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensat” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,653,33439 00For
BlackRock3,594,2550 00For
Fidelity2,798,0921,495 00For
American Century01,977,227 00Against
State Street678,600777 00For
Dimensional0660,050 00Against
Invesco0515,987 00Against
Charles Schwab0380,638 00Against
Royce0341,516 00Against
MFS266,2640 00For
Pacer Funds Trust262,8440 00For
Bridge Builder Trust228,9000 00For
ADVISORS' INNER CIRCLE FUND218,8440 00For
Federated Hermes179,0870 00For
Victory Capital0174,136 00Against
RBB FUND, INC.6,695160,775 00Against
Allspring0167,227 00Against
Goldman Sachs125,47120,299 00Mixed
World Funds Trust127,8230 00For
HUSSMAN INVESTMENT TRUST0120,000 00Against
SEI119,9500 00For
Prudential/PGIM48,22971,179 00Mixed
Equitable63,59438,420 00Mixed
First Trust095,151 00Against
OPTIMUM FUND TRUST87,9000 00For

Fund voting reports, all 98 managers: 14,337,433 for, 5,615,125 against, 19,584 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 271 asset managers voting on “Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensat” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity3,061,2400 00For
American Century02,066,794 00Against
BlackRock1,980,6157,425 00For
State Street1,506,68418,402 00For
GEODE CAPITAL MANAGEMENT, LLC1,309,9480 00For
LSV ASSET MANAGEMENT1,168,7875,000 00For
Boston Partners1,133970,236 00Against
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0617,263 00Against
Charles Schwab0410,954 00Against
Northern Trust357,78121,933 00Mixed
Vanguard353,4111,618 00For
Renaissance0335,329 00Against
Victory Capital0305,098 00Against
AQR0282,050 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/273,5440 00For
Federated Hermes270,3980 00For
PRINCIPAL GLOBAL INVESTORS0260,171 00Against
MELLON INVESTMENTS Corp246,9130 00For
Tieton Capital Management, LLC236,3310 00For
Dimensional0233,503 00Against
Bridgewater227,8020 00For
Valor Management LLC185,1920 00For
Two Sigma0182,091 00Against
Allspring0168,016 00Against
TEXAS PERMANENT SCHOOL FUND CORP0160,219 00Against

Institutional-manager reports, all 271 managers: 13,115,819 for, 8,808,296 against, 161,562 abstained, 1,841 not voted. Showing the 25 largest; see all in the interactive database.

6. 2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public…

Official resultDIRECTOR ELECTIONSReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 49,385,510AGAINST: 830,697
Details: description as filed, official tally, votes by 100 asset managers

Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.

Harmony Biosciences Holdings, Inc.’s own tally for this item (“2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 49,385,510 for, 830,697 against — passed, per its Form 8-K filed May 14, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ended December 31, 2026, was duly ratified.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 100 asset managers below reported 19,917,420 for, 28,443 against, 19,584 abstained.

FOR
FOR: 19,917,420AGAINST: 28,443ABSTAIN: 19,584
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm ” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,653,3712 00For
BlackRock3,594,2550 00For
Fidelity2,799,5870 00For
American Century1,977,2270 00For
State Street679,054323 00For
Dimensional660,0500 00For
Invesco515,9870 00For
Charles Schwab380,6380 00For
Royce341,5160 00For
MFS266,2640 00For
Pacer Funds Trust262,8440 00For
Bridge Builder Trust228,9000 00For
ADVISORS' INNER CIRCLE FUND218,8440 00For
Federated Hermes179,0870 00For
Victory Capital174,1360 00For
Allspring167,2270 00For
RBB FUND, INC.160,7750 00For
Goldman Sachs145,7700 00For
World Funds Trust127,8230 00For
HUSSMAN INVESTMENT TRUST120,0000 00For
SEI119,9500 00For
Prudential/PGIM119,4080 00For
Equitable102,0140 00For
First Trust95,1510 00For
OPTIMUM FUND TRUST87,9000 00For

Showing the 25 largest of 100 asset managers. See all 100 in the interactive database.

Largest Harmony Biosciences Holdings, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 57,867,389 shares outstanding at the time of that meeting.

Fund voting reports: top Harmony Biosciences Holdings, Inc. shareholders by shares voted on “Non-binding, advisory vote on the compensation of our named executive officers pursuant to the…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 8.04%
2BlackRock 6.21%
3Fidelity 4.84%
4American Century 3.42%
5State Street 1.17%
6Dimensional 1.14%
7Invesco 0.89%
8Charles Schwab 0.66%
9Royce 0.59%
10MFS 0.46%
Institutional-manager reports: top Harmony Biosciences Holdings, Inc. shareholders by shares voted on “Non-binding, advisory vote on the compensation of our named executive officers pursuant to the…”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 5.29%
2American Century 3.57%
3BlackRock 3.44%
4State Street 2.64%
5GEODE CAPITAL MANAGEMENT, LLC 2.26%
6LSV ASSET MANAGEMENT 2.03%
7Boston Partners 1.68%
8ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.07%
9Charles Schwab 0.71%
10Northern Trust 0.66%

Reported Harmony Biosciences Holdings, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Harmony Biosciences Holdings, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 12.22% 13F
Marshman Fund Trust II 10.46% DEF14A
Entities affiliated with BlackRock, Inc. 9.97% DEF14A
Vanguard Group 8.32% 13F
FMR (Fidelity) 5.46% 13F
Entities affiliated with FMR LLC (Fidelity) 5.38% DEF14A
Jeffrey S. Aronin 3.78% DEF14A
Andreas Wicki, Ph.D. 3.71% DEF14A
Dimensional Fund Advisors 3.59% 13F
State Street 3.08% 13F

Percentages above are of 57,867,389 shares outstanding, as reported by Harmony Biosciences Holdings, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Harmony Biosciences Holdings, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 7, 2026; a live search always shows the current data.

At Harmony Biosciences Holdings, Inc.'s shareholder meeting held May 14, 2026, in the 2025-2026 proxy season, 344 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 2,502 separate fund positions. On the most widely held item on that ballot — Non-binding, advisory vote on the compensation of our named executive officers pursuant to the… — Harmony Biosciences Holdings, Inc.'s filing reports the proposal as approved, with 72% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Harmony Biosciences Holdings, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 14, 2026.

Harmony Biosciences Holdings, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.